Vertex Pharmaceuticals is laying off workers and consolidating its real estate footprint in Rhode Island after ending a ...

Vertex says the layoffs are due to the discontinuation of a Type 1 diabetes study. The post Boston drug company laying off ...

GSK GSK0.87%increase; green up pointing triangle will acquire a liver-disease treatment from Boston Pharmaceuticals for up to $2 billion as it seeks to boost its pipeline of new drugs. The British ...

Scouting America is proud to announce that Bob Rivers, Executive Chair and Chair of the… Basil Tree Catering is a certified Woman Owned and LGBT Owned Business ...

Under the agreement, GSK will acquire BP Asset IX, a subsidiary of Boston Pharmaceuticals, for up to $2 billion in total cash consideration, including $1.2 billion upfront and up to $800 million in ...

45. LONDON — GSK said Wednesday it would purchase an experimental liver disease medicine from Boston Pharmaceuticals for $1.2 billion upfront, seeking to build up its pipeline of future medicines.

CEO of Boston Pharmaceuticals. "With our robust data, along with the commitment from our Board and a strong funding strategy, we aim to accelerate efimosfermin’s development and begin enrolling ...

The treatment, made by Boston Pharmaceuticals, is ready to enter the last stage of clinical tests, the UK drugmaker said Wednesday. The medicine could become a blockbuster, according to analysts ...